Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir

NCT02337322 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Acquired Immune Deficiency Syndrome Virus

Interventions

DRUG: Dolutegravir
DRUG: Darunavir/r

Sponsor

Juan A. Arnaiz